C

Cordance

Acquires and scales vertical-focused B2B SaaS

VP – Expansion

Full-Time
No salary listed
Expert
Bachelor's, MBA
Remote in USA
Remote
Sales & Account ManagementAccount Management

About the job

Requirements
  • 10–15+ years of experience in revenue leadership roles (e.g., expansion, account management, customer success, or sales)
  • Experience within a software/SaaS environment
  • Proven track record of driving net revenue retention through cross-sell, upsell, and renewals
  • Experience operating across multiple products, business units, or industries
  • Demonstrated success navigating complex organizational structures and aligning diverse stakeholders
  • Strong analytical, forecasting, and pipeline management skills
  • Experience building and scaling high-performing revenue teams
  • Experience designing and implementing scalable playbooks, operating cadences, and cross-functional workflows
  • Bachelor’s degree required
Responsibilities
  • Own and drive cross-sell, upsell, and renewal revenue across all Cordance business units
  • Develop and execute a portfolio-wide expansion strategy across multiple industries and product lines
  • Identify and prioritize high-impact growth opportunities within the existing customer base
  • Align go-to-market teams across business units to drive coordinated account strategies
  • Break down silos and establish consistent processes for identifying and executing expansion opportunities
  • Ensure clear ownership, accountability, and collaboration across teams
  • Oversee renewal strategy and execution to maximize retention and reduce churn
  • Improve adoption, engagement, and long-term value realization
  • Develop lifecycle-based playbooks to drive expansion at key customer milestones
  • Build and manage expansion pipeline, with accurate forecasting across products and business units
  • Establish and track KPIs (net revenue retention, expansion ARR, renewal rates)
  • Improve conversion rates through structured processes, enablement, and performance management
  • Partner with Product and Pricing teams to refine packaging, bundling, and pricing strategies that enable expansion
  • Identify portfolio gaps or friction points that limit cross-sell and influence roadmap priorities
  • Ensure visibility into customer data, usage, and expansion signals across platforms
  • Leverage analytics to identify opportunities and improve targeting and timing
  • Drive CRM and tooling alignment to support multi-product, multi-BU selling
  • Build and lead a high-performing expansion organization (account management, renewals, or hybrid roles)
  • Define roles, incentives, and compensation structures aligned to expansion goals
  • Foster a culture of accountability, collaboration, and customer-centric growth
Desired Qualifications
  • Experience in portfolio or multi-vertical organizations (e.g., private equity-backed or holding company environments)
  • Experience aligning product packaging and pricing with expansion strategy across varied offerings
  • Familiarity with CRM systems and tools supporting multi-product selling
  • MBA or advanced degree

About the company

Cordance buys and grows founder-run, vertically focused B2B SaaS companies using private equity, typically targeting under $10M ARR. It provides financial backing, operational support, and go-to-market leadership, while each acquired company remains its own unit. The portfolio spans industrial distribution, manufacturing, education technology, and secondhand retail, with cross-portfolio collaboration to accelerate growth. The goal is to create durable, long-term value by combining founder insight with strategic ownership and operational excellence.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Raleigh, North Carolina

Founded

2021

Get referred to Cordance

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Cordance acquired AppsAnywhere in October 2025, deepening higher education portfolio coverage.
  • Cordance bought RT Systems in June 2026, expanding warehouse and distribution software capabilities.
  • Cordance added Anand Choubey as CTO in April 2026, strengthening product and AI execution.

What critics are saying

  • Acquisition-led growth needs constant deal flow; PrivSource tracks only two 2026 deals.
  • Pearldive, RT Systems, and Royal 4 increase integration complexity across disparate software stacks.
  • No disclosed funding rounds or major customers leaves Cordance vulnerable to one failed platform.

What makes Cordance unique

  • Cordance bundles vertical SaaS under one operator model, not a passive holding company.
  • LabStats and AppsAnywhere create a differentiated higher-ed software delivery and analytics stack.
  • Raleigh headquarters and founder-preserving acquisitions keep customer-facing continuity after deals.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Unlimited Paid Time Off
  • Parental Leave
  • Remote Work Support
  • Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

0%

2 year growth

3%
Cordance
Oct 14th, 2026
Cordance Acquires AI-Powered CRM Company Designed for Manufacturers

Spiro.ai, the AI-powered CRM platform partners with Cordance for its next phase of growth Raleigh, NC, May 30, 2024 – Cordance, a company that acquires and accelerates the growth of B2B SaaS companies and is a prominent player in the industrial distribution and manufacturing space, announces the successful acquisition of Spiro.ai. This acquisition underscores the […]

Bio-IT World
Mar 11th, 2026
DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. March 11, 2026 Seasoned pharmacy and healthcare technology leader to oversee clinical strategy, biostatistics and scientific innovation JUPITER, FL- March 12, 2026 - DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company's clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe's broader growth objectives, including integration of newly acquired capabilities from Firstline. The combined platform of DoseMe and Firstline unifies evidence-based antimicrobial selection with Bayesian model-informed precision dosing within a single, streamlined clinical workflow. Together, the integrated solution enables health systems to align stewardship strategy, prescribing guidance, and individualized dosing optimization to improve outcomes, reduce resistance risk, and enhance operational efficiency. "Richard's unique combination of frontline clinical expertise, operational leadership, and healthcare technology experience strengthens DoseMe's ability to deliver scientifically rigorous, clinically practical precision dosing solutions," said John Hardesky, CEO of DoseMe. "As we expand our platform with the integration of Firstline's clinical decision support capabilities, his leadership positions us to further advance Bayesian modeling and unified antimicrobial stewardship solutions for health systems worldwide." Malone brings more than 30 years of leadership experience spanning hospital pharmacy operations, investigational drug services, healthcare software, and executive sales leadership. Malone will manage the team of biostatisticians responsible for building and advancing clinical models within the DoseMe platform and serve as the company liaison to the DoseMe Clinical Advisory Board. He will also play a key role in ensuring alignment between scientific innovation and the company's strategic roadmap. "I'm excited to join DoseMe at a time when precision dosing and model-informed drug therapy are becoming central to modern antimicrobial stewardship and patient safety," said Malone. "I look forward to strengthening the company's scientific foundation while supporting scalable growth." Most recently, Malone served as Vice President, Sales at Inovalon, where he led the Care Management business unit's national sales operations. Under his leadership, the team accelerated growth to $3.6 million in new annual contract value in 2024 and achieved greater than 100% net revenue retention, followed by 140% year-over-year ARR growth in the first half of 2025. Prior to Inovalon, Malone was president of McCreadie Group LLC, a healthcare software company acquired by Cordance Operations. During his tenure, the organization achieved 24% year-over-year growth and 28% EBITDA, while expanding its SaaS solutions supporting pharmaceutical research sites and pharmacy residency programs. Malone also brings deep academic medical center experience. He served for nearly a decade as Program Director of the Investigational Drug Service at Vanderbilt University Medical Center, where he led consolidation and expansion of research pharmacy services across the enterprise, improved quality metrics to over 99%, and transitioned the department to a positive operating margin within 12 months. Earlier in his career, he held executive pharmacy leadership roles including Director of Pharmacy at Centennial Medical Center and Maury Regional Medical Center, as well as Corporate Director of Pharmacy Operations for Vanguard Health Systems, overseeing pharmacy strategy across a 25-hospital system. Malone earned his Doctor of Pharmacy with honors from the University of Tennessee College of Pharmacy and a Master of Science in Health Care Administration from the University of Maryland University College. He completed his Pharmacy Practice Residency at Saint Thomas Hospital in Nashville, Tennessee. About DoseMe DoseMe is the provider of Firstline and DoseMeRx clinical decision support technologies that enable proactive, personalized care. Firstline is a mobile-first platform making treatment guidance accessible to every clinician, anywhere. DoseMeRx delivers clinically validated PK/PD models to individualize precision dosing in seconds. DoseMe's evidence-based clinical intelligence helps reduce adverse drug events, antibiotic overuse, improved adherence to stewardship guidance, and provides clinicians a clear path to optimal care. For more information and real-world success stories, visit https://doseme-rx.com/success-stories * News briefs American Journal of Health-System Pharmacy, 2021 * ASHP Executive Forums on Cold Chain Management of Pharmaceuticals in Health Systems American Journal of Health-System Pharmacy * SITC Appoints James Gulley as Vice President ASH Clinical News, 2022 * ASHP Distinguished Leadership Award Kate Traynor, American Journal of Health-System Pharmacy, 2022 * Appointment American Journal of Health-System Pharmacy, 2021

PR Newswire
Oct 9th, 2025
AppsAnywhere Joins Cordance to Boost Innovation

Cordance has acquired AppsAnywhere to enhance software access and delivery in higher education IT. This acquisition aims to expand capabilities in application delivery and IT efficiency, promoting digital equity for students. AppsAnywhere, trusted by over 300 institutions, will align with LabStats, another Cordance company, to optimize software delivery and usage analytics. This move supports higher education leaders in meeting diverse student expectations and improving IT efficiencies.

PR Newswire
Jan 22nd, 2024
Tequity Advises SaaS Supply Chain ERP Provider, Blue Link Associates, on Strategic Acquisition by Cordance

Blue Link Associates Limited, the all-in-one, wholesale distribution inventory management and accounting software system, partners with Cordance for growth

BuildCentrix
Nov 15th, 2023
Cordance Acquires BuildCentrix

Cordance Acquires BuildCentrix BuildCentrix, a leading construction workflow optimization and collaboration platform, partners with Cordance to accelerate growth